The following are the top rated Information Technology stocks according to Validea's Patient Investor model based on the published strategy of Warren Buffett. This strategy seeks out firms with long-term, predictable profitability and low debt that trade at reasonable valuations.
The following are the top rated Information Technology stocks according to Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance
The following are the top rated Information Technology stocks according to Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low
The following are the top rated Information Technology stocks according to Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.CISCO SYSTEMS INC (CSCO) is
Sanofi SNY announced that the FDA has accepted the supplemental biologics license application (sBLA), seeking expanded use of its multiple myeloma drug, Sarclisa (isatuximab).
Since the announcement of the Ambition 2025 plan on Feb 24, 2022, Beacon Roofing Supply, Inc. BECN has been intently focusing on seeking and capturing opportunities to fulfill the stated targets and foster its growth along the way
The near-term prospects of the Zacks Medical-Hospital industry will be shaped by various factors, including rising patient volumes, resumption of elective procedures, and technological and cybersecurity advancements. While in
At its core, investing is all about the future. In typical approaches that try to put a value on a company's stock, prospective investors start by estimating the amount of money the company will generate for its owners over time.
Below is Validea's guru fundamental report for CHAMPIONX CORP (CHX). Of the 22 guru strategies we follow, CHX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative t
Below is Validea's guru fundamental report for LANTHEUS HOLDINGS INC (LNTH). Of the 22 guru strategies we follow, LNTH rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price r
Below is Validea's guru fundamental report for MOHAWK INDUSTRIES INC (MHK). Of the 22 guru strategies we follow, MHK rates highest using our Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long
Below is Validea's guru fundamental report for ASE TECHNOLOGY HOLDING CO LTD (ADR) (ASX). Of the 22 guru strategies we follow, ASX rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. This momentum model looks for a combination of
(RTTNews) - Elon Musk's artificial intelligence startup xAI has secured $6 billion in its Series B round to accelerate its challenge to his former allies at OpenAI.
(RTTNews) - Overall survival results from the TROPION-Lung01 phase 3 trial numerically favored Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan (Dato-DXd) compared to docetaxel in the overall trial population of adult patients with locally advanced or metastatic non-small
(RTTNews) - Alstom said it has launched a share capital increase with preferential subscription rights for an amount of about 1 billion euros, thus executing the final step of the announced 2 billion euros deleveraging plan.
(RTTNews) - Strauss Group Ltd. (SGLJF.PK), an Israeli food and beverage company, reported that its income attributable to the company's shareholders for the first quarter dropped to 51 million New Israeli Shekel from 231 million Shekel in the previous year.
(RTTNews) - Polymetals Resources Ltd (POL.AX) said that it has formed a non-exclusive strategic alliance with Metals Acquisition Limited (MAC.AX) to advance synergies aiming to extract greater value from both the Endeavor and CSA Copper Mines, both located in the Cobar Basin, NSW
(RTTNews) - Sanofi - Aventis Groupe said that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application (sBLA) for the investigational use of Sarclisa or isatuximab in combination with bortezomib, lenalidomide and dexame
(RTTNews) - Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration, Roche said in a statement on Monday.